
|Poll|October 17, 2022
Poll results: Will you use biosimilars in your ophthalmic practice?
Author(s)Sheryl Stevenson, OT Staff Reports
Results from our recent poll indicate that many ophthalmologists (63%) plan to use biosimilars in their clinical practice.
Advertisement
Ophthalmology Times® polled our audience with the following question from September 26, 2022 to October 10, 2022: Will you use biosimilars in your ophthalmic practice?
The poll appeared on
37 responses were recorded, in total. Of these:
23% responded, "Yes, I plan to use biosimilars in my practice."
14% responded, "No, I do not plan to use biosimilars in my practice."
.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Duravyu misses LUGANO endpoint but cuts treatment burden by 42%
4
EURETINA 2026: Eyestem interim Phase 2 results for clinical study of Eyecyte-RPE for GA secondary to dry AMD
5


















